To understand how changes in the PsKD of MLKL control the transition between monomer and tetramer, we introduced a series of mutations into full-length hMLKL guided by XL-MS, HDX-MS, and residues mutated in human cancer specimens (Fig. 4a, Table 1). Here, MLKL is linked to cancer.